The State Food and Drug Administration recently issued a notice, which has been tested by 4 drug inspection institutions including Hubei Provincial Institute of Drug Supervision and Inspection, and marked as produced by 14 companies including Shanxi Guorun Pharmaceutical Co., Ltd., Hubei Tongdetang Pharmaceutical Co., Ltd. 17 batches of medicines, including acetylcysteine injection, Huoxiangzhengqi water , etc., did not meet the regulations.
According to the announcement, the two batches of acetylcysteine injections marked as produced by Shanxi Guorun Pharmaceutical Co., Ltd. were inspected by Hubei Provincial Institute of Drug Supervision and Inspection as non-compliant, and the non-compliant items were hydrogen sulfide . It is reported that the sulfhydryl of acetylcysteine sulfhydryl is shed during the production or storage process of hydrogen sulfide, which may be related to the production sterilization process or storage conditions.
has been inspected by Jiangxi Provincial Drug Inspection and Testing Institute , and it is marked as two batches of Huoxiangzhengqi water produced by Hubei Tongdetang Pharmaceutical Co., Ltd. that do not meet the regulations, and the non-compliant items are the amount of methanol and . It is reported that the amount of methanol reflects the content of methanol that may be brought by ethanol in ethanol-containing preparations such as liquor or tincture.
has been tested by China Institute for Food and Drug Control , and is marked as Hebei Anguo Zhenyu Pharmaceutical Co., Ltd., Shanghai Wanshicheng Pharmaceutical Co., Ltd., Shaoxing Zhenyuan Traditional Chinese Medicine Decoction Piece Co., Ltd., Anhui Tongtai Tuozutang Pharmaceutical Co., Ltd. 8 batches of chrysanthemum produced by Bozhou Shenghai Traditional Chinese Medicine Co., Ltd., Jiangxi Zhongkang Traditional Chinese Medicine Co., Ltd., Guangdong Shizhen Pharmaceutical Co., Ltd. and Gansu National Herbal Medicine Co., Ltd. did not meet the regulations, and the items that did not meet the regulations were banned pesticides residual amount.
has been inspected by Gansu Provincial Institute of Drug Inspection and marked as Sichuan Yuanshang Herbal Traditional Chinese Medicine Pieces Co., Ltd. produced a batch of madder that does not meet the regulations, and the non-compliant items include traits and identification.
has been inspected by China National Institute for Food and Drug Control, and it is marked as 4 batches of comfrey produced by Hebei Honghan Pharmaceutical Co., Ltd., Xinjiang Enze Traditional Chinese Medicine Co., Ltd. and Huazhou Huayi Traditional Chinese Medicine Co., Ltd. Provisions, items that do not meet the provisions are traits.
It is reported that the appearance, odor, taste, solubility, and physical constants are recorded under the properties, which reflect the quality characteristics of the drug to a certain extent. The properties of Chinese herbal decoction pieces do not meet the regulations, which may involve the deviation of the species of medicinal materials, defective processing technology, improper storage, etc. The identification item is mainly used to distinguish the characteristics of medicines, and its methods include microscopic identification, spectral identification, etc. commonly used identification methods.
The State Food and Drug Administration stated that for the above-mentioned non-compliant drugs, the drug supervision and management department has required relevant enterprises and units to take risk control measures such as suspension of sales and use, recall, etc., to investigate the reasons for non-compliance and make rectifications.
In addition, the State Food and Drug Administration requires the relevant provincial drug supervision and administration departments to organize investigations into the suspected illegal activities of the above-mentioned enterprises and units in accordance with the " The Drug Administration Law of the People's Republic of China ", and publicize the results of the investigation and punishment according to regulations.
Screenshot of the official website of the State Food and Drug Administration
